Albuquerque, NM, March 27, 2014 --(PR.com
)-- Sheldon K. Jordan, PhD, President and CEO, Peptineo, announces the appointment of Sundar Nadarajan, PhD, to the company's Scientific Advisory Board. They are extremely pleased that Dr. Nadarajan has joined the Peptineo Scientific Advisory Board. "He is an accomplished scientist and consulting expert in the field of biomaterials, nanotechnology, drug delivery and sensor development," noted Dr. Jordan.
Dr. Nadarajan’s primary focus during his tenure at Drexel University was developing biomedical applications based on nanotechnology. Dr. Nadarajan then established methods for preparation of nanosomes that subsequently led to formulating a topical cream minimizing skin damage from UV rays. His expertise in biomaterials also helped his team further develop biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine.
Dr. Nadarajan combines a unique background with hands-on academic experience positioning him to thrive in various research-related projects. As research faculty, he spearheaded nanotechnology centric biomedical engineering research projects, including encompassing hydrogels for sustained drug release, an optically driven “on-demand” insulin delivery system, and an ultrasound mediated release of drugs from nanocapsules. Additionally, he also pioneered product development on quantum dots and metallic nanoparticles that found applications in determining the disease response rate to treatments and leveraged a driving force in any biochemical reactions namely protein-protein interactions.
Dr. Nadarajan’s career highlights include: overseeing the direct synthesis of water/oil/water (PLGA/PVA) nanoparticles using dual asymmetric axis centrifuge. He has also developed methods to prepare nanosomes below 50 nm in diameter and high aspect ratio. Currently, he has a patent pending for designing a means for preparing carbon nanocapsules. A talented and astute professional, Dr. Nadarajan has co-authored several proposals for federal funding agencies such as NSF and NIH.
"We are very excited to have Dr. Nadarajan as a member of our Scientific Advisory Board and look forward to his input in tunable nano-carriers and large molecule drug delivery processes," noted Dr. Jordan.